EUVIMEDEUVIMED entdecken
Crossref

Dual Cardiometabolic Disorders: An Overview of Co-Existing Type 2 Diabetes Mellitus and Hypertension

Prof. (Dr.) Rahul Bijwar, Prof. Kajal A. Mantriwar, Prof. Subodh Dhone, Miss Vaishnavi Ughade

International Journal of Advanced Research in Science Communication and Technology · 21.11.2026 · 134

DOI: 10.48175/ijarsct-40917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Advanced Research in Science Communication and Technology, online erschienen am 21.11.2026. Verfasst von Prof. (Dr.) Rahul Bijwar und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) and hypertension are common chronic disorders that frequently coexist and substantially increase the risk of cardiovascular disease, stroke, and kidney complications. Their association is supported by shared mechanisms, including insulin resistance, chronic low-grade inflammation, oxidative stress, endothelial dysfunction, and activation of the renin–angiotensin–aldosterone system (RAAS). Persistent hyperglycaemia contributes to vascular injury, while elevated blood pressure can accelerate renal and cardiovascular damage and is commonly associated with metabolic dysfunction. This narrative review summarizes the epidemiology and shared risk factors of T2DM and hypertension, explains their interrelated pathophysiology, and discusses symptoms, diagnosis, lifestyle measures, and pharmacological management. Antidiabetic treatment may include metformin, sodium–glucose cotransporter-2 inhibitors, and glucagon-like peptide-1 receptor agonists, selected according to individual clinical characteristics. Antihypertensive treatment may include angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, and thiazide-like diuretics. Calcium channel blocker mechanisms and important adverse effects are also reviewed. Integrated care, early detection, individualized treatment, and regular monitoring of blood glucose, blood pressure, kidney function, and cardiovascular risk are essential to reduce complications.

Zitieren

APA

Bijwar, P. D. R., Mantriwar, P. K. A., Dhone, P. S., & Ughade, M. V. (2026). Dual Cardiometabolic Disorders: An Overview of Co-Existing Type 2 Diabetes Mellitus and Hypertension. International Journal of Advanced Research in Science Communication and Technology, 134. https://doi.org/10.48175/ijarsct-40917

Vancouver

Bijwar PDR, Mantriwar PKA, Dhone PS, Ughade MV. Dual Cardiometabolic Disorders: An Overview of Co-Existing Type 2 Diabetes Mellitus and Hypertension. International Journal of Advanced Research in Science Communication and Technology. 2026:134. doi:10.48175/ijarsct-40917

BibTeX
@article{Bijwar2026,
  author = {Bijwar, Prof. (Dr.) Rahul and Mantriwar, Prof. Kajal A. and Dhone, Prof. Subodh and Ughade, Miss Vaishnavi},
  title = {Dual Cardiometabolic Disorders: An Overview of Co-Existing Type 2 Diabetes Mellitus and Hypertension},
  journal = {International Journal of Advanced Research in Science Communication and Technology},
  year = {2026},
  pages = {134},
  doi = {10.48175/ijarsct-40917}
}
Kostenlos starten →